Orbimed Advisors LLC Selecta Biosciences Inc Transaction History

Orbimed Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.82 - $5.01 $956,456 - $1.7 Million	-339,169 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $584,000 - $1.01 Million	-200,000 Reduced 37.09%	339,169 $1.54 Million
Q4 2020 Feb 16, 2021	SELL	$1.64 - $3.42 $2.55 Million - $5.32 Million	-1,554,700 Reduced 74.25%	539,169 $1.63 Million
Q2 2020 Aug 14, 2020	SELL	$1.83 - $4.06 $915,000 - $2.03 Million	-500,000 Reduced 19.28%	2,093,869 $5.95 Million
Q1 2020 May 15, 2020	SELL	$1.5 - $4.52 $427,792 - $1.29 Million	-285,195 Reduced 9.91%	2,593,869 $6.25 Million
Q1 2019 May 15, 2019	BUY	$1.47 - $3.06 $1.91 Million - $3.98 Million	1,300,000 Added 82.33%	2,879,064 $6.82 Million
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $302,529 - $1.81 Million	-113,733 Reduced 6.72%	1,579,064 $4.2 Million
Q3 2018 Nov 14, 2018	SELL	$12.07 - $16.0 $1.81 Million - $2.4 Million	-150,000 Reduced 8.14%	1,692,797 $26.3 Million
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $28 Million - $36.9 Million	1,842,797	1,842,797 $33.6 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.